ANKRD33B-AS1

Across TCGA pan-cancer cohorts, ANKRD33B-AS1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ANKRD33B-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ANKRD33B-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ANKRD33B-AS1 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC, KIRP, and BRCA are the cancer types where ANKRD33B-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ANKRD33B-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.073	.002	4	view →
KIRP	All	IV	+0.162	.044	2	view →
BRCA	All	III,IV	−0.031	.042	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ANKRD33B-AS1–KIRC

Open the KIRC breakdown →